188 related articles for article (PubMed ID: 23938054)
1. Chronic overload of SEPT4, a parkin substrate that aggregates in Parkinson's disease, causes behavioral alterations but not neurodegeneration in mice.
Ageta-Ishihara N; Yamakado H; Morita T; Hattori S; Takao K; Miyakawa T; Takahashi R; Kinoshita M
Mol Brain; 2013 Aug; 6():35. PubMed ID: 23938054
[TBL] [Abstract][Full Text] [Related]
2. Sept4, a component of presynaptic scaffold and Lewy bodies, is required for the suppression of alpha-synuclein neurotoxicity.
Ihara M; Yamasaki N; Hagiwara A; Tanigaki A; Kitano A; Hikawa R; Tomimoto H; Noda M; Takanashi M; Mori H; Hattori N; Miyakawa T; Kinoshita M
Neuron; 2007 Feb; 53(4):519-33. PubMed ID: 17296554
[TBL] [Abstract][Full Text] [Related]
3. Expression of Lewy body protein septin 4 in postmortem brain of Parkinson's disease and control subjects.
Shehadeh L; Mitsi G; Adi N; Bishopric N; Papapetropoulos S
Mov Disord; 2009 Jan; 24(2):204-10. PubMed ID: 18951507
[TBL] [Abstract][Full Text] [Related]
4. AAV1/2-induced overexpression of A53T-α-synuclein in the substantia nigra results in degeneration of the nigrostriatal system with Lewy-like pathology and motor impairment: a new mouse model for Parkinson's disease.
Ip CW; Klaus LC; Karikari AA; Visanji NP; Brotchie JM; Lang AE; Volkmann J; Koprich JB
Acta Neuropathol Commun; 2017 Feb; 5(1):11. PubMed ID: 28143577
[TBL] [Abstract][Full Text] [Related]
5. Lentiviral vector delivery of parkin prevents dopaminergic degeneration in an alpha-synuclein rat model of Parkinson's disease.
Lo Bianco C; Schneider BL; Bauer M; Sajadi A; Brice A; Iwatsubo T; Aebischer P
Proc Natl Acad Sci U S A; 2004 Dec; 101(50):17510-5. PubMed ID: 15576511
[TBL] [Abstract][Full Text] [Related]
6. Association of the cytoskeletal GTP-binding protein Sept4/H5 with cytoplasmic inclusions found in Parkinson's disease and other synucleinopathies.
Ihara M; Tomimoto H; Kitayama H; Morioka Y; Akiguchi I; Shibasaki H; Noda M; Kinoshita M
J Biol Chem; 2003 Jun; 278(26):24095-102. PubMed ID: 12695511
[TBL] [Abstract][Full Text] [Related]
7. Dopamine-dependent neurodegeneration in rats induced by viral vector-mediated overexpression of the parkin target protein, CDCrel-1.
Dong Z; Ferger B; Paterna JC; Vogel D; Furler S; Osinde M; Feldon J; Büeler H
Proc Natl Acad Sci U S A; 2003 Oct; 100(21):12438-43. PubMed ID: 14530399
[TBL] [Abstract][Full Text] [Related]
8. Inclusion body formation and neurodegeneration are parkin independent in a mouse model of alpha-synucleinopathy.
von Coelln R; Thomas B; Andrabi SA; Lim KL; Savitt JM; Saffary R; Stirling W; Bruno K; Hess EJ; Lee MK; Dawson VL; Dawson TM
J Neurosci; 2006 Apr; 26(14):3685-96. PubMed ID: 16597723
[TBL] [Abstract][Full Text] [Related]
9. Bacterial artificial chromosome transgenic mice expressing a truncated mutant parkin exhibit age-dependent hypokinetic motor deficits, dopaminergic neuron degeneration, and accumulation of proteinase K-resistant alpha-synuclein.
Lu XH; Fleming SM; Meurers B; Ackerson LC; Mortazavi F; Lo V; Hernandez D; Sulzer D; Jackson GR; Maidment NT; Chesselet MF; Yang XW
J Neurosci; 2009 Feb; 29(7):1962-76. PubMed ID: 19228951
[TBL] [Abstract][Full Text] [Related]
10. Septin 4, the drosophila ortholog of human CDCrel-1, accumulates in parkin mutant brains and is functionally related to the Nedd4 E3 ubiquitin ligase.
Muñoz-Soriano V; Nieto-Arellano R; Paricio N
J Mol Neurosci; 2012 Sep; 48(1):136-43. PubMed ID: 22562816
[TBL] [Abstract][Full Text] [Related]
11. [Etiology and pathogenesis of Parkinson's disease: from mitochondrial dysfunctions to familial Parkinson's disease].
Hattori N
Rinsho Shinkeigaku; 2004; 44(4-5):241-62. PubMed ID: 15287506
[TBL] [Abstract][Full Text] [Related]
12. Parkin interacting substrate zinc finger protein 746 is a pathological mediator in Parkinson's disease.
Brahmachari S; Lee S; Kim S; Yuan C; Karuppagounder SS; Ge P; Shi R; Kim EJ; Liu A; Kim D; Quintin S; Jiang H; Kumar M; Yun SP; Kam TI; Mao X; Lee Y; Swing DA; Tessarollo L; Ko HS; Dawson VL; Dawson TM
Brain; 2019 Aug; 142(8):2380-2401. PubMed ID: 31237944
[TBL] [Abstract][Full Text] [Related]
13. Ubiquitination of a new form of alpha-synuclein by parkin from human brain: implications for Parkinson's disease.
Shimura H; Schlossmacher MG; Hattori N; Frosch MP; Trockenbacher A; Schneider R; Mizuno Y; Kosik KS; Selkoe DJ
Science; 2001 Jul; 293(5528):263-9. PubMed ID: 11431533
[TBL] [Abstract][Full Text] [Related]
14. Parkin-deficient mice exhibit nigrostriatal deficits but not loss of dopaminergic neurons.
Goldberg MS; Fleming SM; Palacino JJ; Cepeda C; Lam HA; Bhatnagar A; Meloni EG; Wu N; Ackerson LC; Klapstein GJ; Gajendiran M; Roth BL; Chesselet MF; Maidment NT; Levine MS; Shen J
J Biol Chem; 2003 Oct; 278(44):43628-35. PubMed ID: 12930822
[TBL] [Abstract][Full Text] [Related]
15. Parkin promotes degradation of the mitochondrial pro-apoptotic ARTS protein.
Kemeny S; Dery D; Loboda Y; Rovner M; Lev T; Zuri D; Finberg JP; Larisch S
PLoS One; 2012; 7(7):e38837. PubMed ID: 22792159
[TBL] [Abstract][Full Text] [Related]
16. α-synuclein expression from a single copy transgene increases sensitivity to stress and accelerates neuronal loss in genetic models of Parkinson's disease.
Cooper JF; Spielbauer KK; Senchuk MM; Nadarajan S; Colaiácovo MP; Van Raamsdonk JM
Exp Neurol; 2018 Dec; 310():58-69. PubMed ID: 30194957
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of Septin 4, the Drosophila homologue of human CDCrel-1, is toxic for dopaminergic neurons.
Muñoz-Soriano V; Paricio N
Eur J Neurosci; 2007 Dec; 26(11):3150-8. PubMed ID: 18028112
[TBL] [Abstract][Full Text] [Related]
18. Parkin depletion delays motor decline dose-dependently without overtly affecting neuropathology in α-synuclein transgenic mice.
Fournier M; Roux A; Garrigue J; Muriel MP; Blanche P; Lashuel HA; Anderson JP; Barbour R; Huang J; du Montcel ST; Brice A; Corti O
BMC Neurosci; 2013 Nov; 14():135. PubMed ID: 24192137
[TBL] [Abstract][Full Text] [Related]
19. Synapsin III deficiency hampers α-synuclein aggregation, striatal synaptic damage and nigral cell loss in an AAV-based mouse model of Parkinson's disease.
Faustini G; Longhena F; Varanita T; Bubacco L; Pizzi M; Missale C; Benfenati F; Björklund A; Spano P; Bellucci A
Acta Neuropathol; 2018 Oct; 136(4):621-639. PubMed ID: 30046897
[TBL] [Abstract][Full Text] [Related]
20. Interaction between Parkin and
Madsen DA; Schmidt SI; Blaabjerg M; Meyer M
Cells; 2021 Jan; 10(2):. PubMed ID: 33572534
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
